SCHEMBL3715552

SCHEMBL3715552

Cc1cc(Br)ccc1S(=O)(=O)N1CCN(C(=O)c2ccccc2)[C@@H](C)C1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CNR1 P21554 1/20 0.42
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
EPHX2 P34913 3/20 0.41
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMO Q99835 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2834513 0.88 EPHX2 (0.45) CNR1GAALMNAEPHX2HCRTR1
SCHEMBL2840532 0.88 EPHX2 (0.45) CNR1GAALMNAEPHX2HCRTR1
SCHEMBL3713761 0.85 PDK2 (0.46) HTTL3MBTL1CNR1EPHX2SMO
SCHEMBL309655 0.81 F13A1 (0.48) EPHX2HCRTR1HCRTR2MAPT
SCHEMBL12965416 0.81 F13A1 (0.48) EPHX2HCRTR1HCRTR2MAPT
SCHEMBL752288 0.78 TSHR (0.60) HTTL3MBTL1GAALMNASMO
SCHEMBL3713949 0.76 ATM (0.50) L3MBTL1CNR1SMO
SCHEMBL5321245 0.74 HTT (0.51) HTTL3MBTL1SMO
SCHEMBL5653994 0.74 HTT (0.51) HTTL3MBTL1SMO
SCHEMBL3713826 0.74 SMO (0.52) L3MBTL1CNR1LMNAPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010102663-A1 PIPERAZINE DERIVATIVES FOR USE IN THERAPY GLAXO GROUP LIMITED (GB) 2010-09-16 WO claimed
WO-2010102663-A1 PIPERAZINE DERIVATIVES FOR USE IN THERAPY GLAXO GROUP LIMITED (GB) 2010-09-16 WO disclosed
WO-2010102663-A1 PIPERAZINE DERIVATIVES FOR USE IN THERAPY GLAXO GROUP LIMITED (GB) 2010-09-16 WO disclosed